These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G. J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795 [Abstract] [Full Text] [Related]
3. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. White D, Leigh A, Wilson C, Donaldson A, Franks S. Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565 [Abstract] [Full Text] [Related]
4. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome. Wu X, Sallinen K, Zhou S, Su Y, Pöllänen P, Erkkola R. Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533 [Abstract] [Full Text] [Related]
5. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome. Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A. Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108 [Abstract] [Full Text] [Related]
6. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome. Fruzzetti F, De Lorenzo D, Ricci C, Teti G. Fertil Steril; 1995 Apr; 63(4):734-41. PubMed ID: 7890056 [Abstract] [Full Text] [Related]
18. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S. Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739 [Abstract] [Full Text] [Related]